Doximity shares are trading higher after Truist Securities raised its price target on the stock from $19 to $24.

Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf

Grabar Law Office announced investigations into potential breaches of fiduciary duties by officers and directors at Doximity, GoDaddy, Planet Fitness, and PROCEPT BioRobotics. The investigations follow federal securities class action filings alleging misleading statements regarding business metrics, pricing strategies, and financial guidance. Long-term shareholders meeting specific holding periods are eligible to seek corporate reforms and potential compensation at no cost.

Shareholders who lost money in shares of acquired Doximity, Inc. (NYSE: DOCS) should contact Wolf Haldenstein Immediately

Wolf Haldenstein has filed class action lawsuits against Doximity, Papa John's International, and Hims & Hers Health on behalf of shareholders who suffered losses. The lawsuits allege that these companies made false or misleading statements regarding their financial performance and business prospects. Doximity's stock declined significantly following multiple guidance misses and revenue warnings between November 2025 and May 2026.

Freedom Capital Markets Downgrades Doximity to Hold, Raises Price Target to $27

Barclays Maintains Equal-Weight on Doximity, Raises Price Target to $27

Barclays analyst Glen Santangelo maintains Doximity (NYSE:DOCS) with a Equal-Weight and raises the price target from $20 to $27.